Jinshi data January 16 news, Hong Kong stock Xinda Biology (01801.HK) flash crash in intraday trading, the stock price fell more than 14% at one point. In response to the above dynamics, Xinda Biology told reporters that it has noticed the abnormal fluctuations in the company's stock price and transaction volume in the afternoon. The company's business operations are normal and there have been no changes; at present, the company's products in the approval process such as Mastide peptide, Trastuzumab, and Pyrrolobenzodiazepine progress smoothly and have not changed.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Innovent, hisse senedi fiyatlarındaki ani düşüşe yanıt veriyor: şirket ve onaylanan ürün normal şekilde ilerliyor
Jinshi data January 16 news, Hong Kong stock Xinda Biology (01801.HK) flash crash in intraday trading, the stock price fell more than 14% at one point. In response to the above dynamics, Xinda Biology told reporters that it has noticed the abnormal fluctuations in the company's stock price and transaction volume in the afternoon. The company's business operations are normal and there have been no changes; at present, the company's products in the approval process such as Mastide peptide, Trastuzumab, and Pyrrolobenzodiazepine progress smoothly and have not changed.